Table 3 Baseline characteristics for the three treatment groups
From: The treatment of medial tibial stress syndrome in athletes; a randomized clinical trial
| Â | Running program (SD) N = 25 | Running program + exercises (SD) N = 24 | Running program + compression stocking (SD) N = 25 | p-value |
|---|---|---|---|---|
Height (centimeters) | 175,4 (4,9) | 171,6 (5,1) | 177,0 (9,9) | NS |
Weight (kilograms) | 68,7 (8,1) | 68,3 (7,7) | 70,4 (11,2) | NS |
BMI (kilograms/(length) 2 ) | 22,2 (1,8) | 22,9 (2,6) | 22,3 (2,6) | NS |
Age (years) | 22,2 (6,8) | 20,7 (6,4) | 23,0 (8,2) | NS |
Sex (percentage females) | 65,2% | 72,7% | 53,5% | NS |
Side with complaints (percentage bilateral complaints) | 87,0% | 77,3% | 96,4% | NS |
Centimeters of pain on palpation | 12,2 (4,9) | 11,6 (5,1) | 16,1 (8,8) | NS |
Days with complaints | 178,0 (319,2) | 174,0 (274,1) | 213,7 (363,8) | NS |
Meters run without pain on treadmill | 708,7 (423,9) | 572,6 (419,2) | 591,8 (427,2) | NS |
| Â | Phase 1: 36% Phase 2: 28% Phase 3: 24% Phase 4: 12% | Phase 1: 38% Phase 2: 33% Phase 3: 17% Phase 4: 13% | Phase 1: 44% Phase 2: 28% Phase 3: 16% Phase 4: 20% | NS |